BAXBaxter International Inc.
AI adoption · Q1 2026 earnings call
Health CarePiloting
2
extracted from this call
3 / 5
operational, no hard numbers
Not disclosed
no breakout in this call
Baxter's CEO briefly referenced AI in two contexts during prepared remarks: AI-integrated product features in its Connected Care Foundation platform (leveraging IoT device data from beds, pumps, and vitals monitors) and internal AI tools being deployed to accelerate quality workflow efficiency, specifically customer correspondence and corrective field action communications. No financial quantification of AI investments or revenue impact was provided, and AI was not a focus of analyst Q&A.
Adopter
See full leaderboard →33/ 100
51
stage: piloting · max spec: 3
0
no quantified disclosure
65
2 scopes
product_embeddedinternal_use
2 AI mentions from this call.
Extracted verbatim from the BAX Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T3Prepared remarks· CEO· Internal use
“We have also started to deploy AI tools to accelerate efficiency gains within internal quality workflows, such as the customer correspondence and AI-assisted corrective field action communications scheduled to be deployed later this year. Looking forward, we will thoughtfully embed AI directly into internal process improvements, frontline workflows and manufacturing at enterprise scale, with the goal of strengthening speed consistency, reliability while also maintaining rigorous governance and a focus on patient safety.”
— Andrew Hider, BAX earnings call - T3Prepared remarks· CEO· Product-embedded AI
“We also have an active pipeline of differentiated solutions with integrated AI functionality, designed to accelerate future growth. We are already leveraging AI in our Connected Care Foundation, which unifies Baxter's unique data set provided by [ Internet of Things ] devices like beds, pumps and vitals to provide actionable data and analysis. In addition, we are using AI in frontline care to develop products that strengthen clinical insights and operational efficiency.”
— Andrew Hider, BAX earnings callConnected Care Foundation
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- No quantification of AI-related investment (capex or opex) was provided.
- No revenue attribution or ARR associated with AI-enabled products was disclosed.
- No adoption metrics, user counts, or productivity outcomes from AI tools were shared.
- The timeline for enterprise-scale AI deployment in internal processes and manufacturing was described only as forward-looking with no specific milestones or dates.
- No analyst asked a direct question about AI strategy or AI investment, so no additional disclosure was elicited in Q&A.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.